Correlation Between Walker Dunlop and Celltrion Pharm
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and Celltrion Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and Celltrion Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and Celltrion Pharm, you can compare the effects of market volatilities on Walker Dunlop and Celltrion Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of Celltrion Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and Celltrion Pharm.
Diversification Opportunities for Walker Dunlop and Celltrion Pharm
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Walker and Celltrion is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and Celltrion Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celltrion Pharm and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with Celltrion Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celltrion Pharm has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and Celltrion Pharm go up and down completely randomly.
Pair Corralation between Walker Dunlop and Celltrion Pharm
Allowing for the 90-day total investment horizon Walker Dunlop is not expected to generate positive returns. Moreover, Walker Dunlop is 1.68 times more volatile than Celltrion Pharm. It trades away all of its potential returns to assume current level of volatility. Celltrion Pharm is currently generating about -0.48 per unit of risk. If you would invest 9,462 in Walker Dunlop on November 6, 2024 and sell it today you would lose (44.00) from holding Walker Dunlop or give up 0.47% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 89.47% |
| Values | Daily Returns |
Walker Dunlop vs. Celltrion Pharm
Performance |
| Timeline |
| Walker Dunlop |
| Celltrion Pharm |
Walker Dunlop and Celltrion Pharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Walker Dunlop and Celltrion Pharm
The main advantage of trading using opposite Walker Dunlop and Celltrion Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, Celltrion Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celltrion Pharm will offset losses from the drop in Celltrion Pharm's long position.| Walker Dunlop vs. Mr Cooper Group | Walker Dunlop vs. Velocity Financial Llc | Walker Dunlop vs. Security National Financial | Walker Dunlop vs. Encore Capital Group |
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Celltrion Pharm as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Celltrion Pharm's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Celltrion Pharm's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Celltrion Pharm.
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |